Company / Gross Profit per Share
AXIM BIOTECHNOLOGIES, INC. Gross Profit per Share History
FY2015-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.00
FY2018
5-year range
-$0.00 / $0.00
FY2015-FY2018
Trend
+3717.8%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share changed +3718% YoY in FY2018, a notable deviation from the 3-year average annual change of -1074%.
Based on SEC 10-K filings.
0.00 in FY2018.
Improved from $-0.00 to $0.00 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, gross profit per share increased 3717.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2018 | $0.00 | +3717.8% |
| FY2017 | $0.00 | +103.3% |
| FY2016 | -$0.00 | -7043.4% |
| FY2015 | -$0.00 | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2018 · SEC 10-K · Updated Jun 29, 2026